glp 1 polycystic kidney disease GLP‐1RA Semaglutide Delays the Progression of ADPKD Through Regulation of Glycolysis, Mitochondria Function and Ketosis - Wu - 2025 - The FASEB Journal The dual impact of GLP-1
Description
Patients who lost less than 20 pounds on GLP-1 medications and were subsequently prescribed phentermine experienced greater weight loss while on phentermine in the year following GLP-1 treatment than patients who lost at least 20 pounds on the GLP-1 medication.
GLP-1 agonists are pivotal in obesity care, promoting weight loss and addressing related health issues, with a focus on personalized, holistic treatment.
The weight came back
Dulaglutide is a long-acting GLP-1 receptor agonist used for type 2 diabetes and weight management
Human data (from a meta-analysis of 894 participants) show fenugreek supplementation (0.5 g to 10 g daily over 4 weeks to 6 months) reduces fasting glucose, post-meal glucose, and HbA1c
Discover how Danone's Oikos Fusion yogurt drink caters to weight management and muscle retention, particularly for those using GLP-1 medications
